Clinical Trials
5 trialsNCT05675410 2026-06-03
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT07624838 2026-06-03
Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Recruiting
NCT04685616 2026-06-02
RADAR
University College, London
Phase 3 Recruiting
NCT07013565 2026-05-20
ACCELERATE
New York Medical College
Phase 2 Recruiting
NCT03007030 2026-05-15
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
Phase 2 Recruiting